Standard Biotools (LAB) EBITDA Margin Growth (1y) (2011 - 2026)
Standard Biotools (LAB) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 146.00 |
| 10 | Standard Biotools | 256.97 Mn | -219.75 Mn | 10.54 Mn | -820.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -820.00 |
| Mar 31, 2026 | 7,428.00 |
| Dec 31, 2025 | 170.00 |
| Sep 30, 2025 | -4,758.00 |
| Jun 30, 2025 | 1,646.00 |
| Mar 31, 2025 | -122.00 |
| Dec 31, 2024 | -2,940.00 |
| Sep 30, 2024 | -3,742.00 |
| Jun 30, 2024 | -7,147.00 |
| Mar 31, 2024 | -6,609.00 |
| Dec 31, 2023 | 226.00 |
| Sep 30, 2023 | 2,972.00 |
| Jun 30, 2023 | 14,230.00 |
| Mar 31, 2023 | 3,771.00 |
| Sep 30, 2022 | -5,231.00 |
| Jun 30, 2022 | -14,804.00 |
| Mar 31, 2022 | -4,486.00 |
| Sep 30, 2021 | -4,717.00 |
| Jun 30, 2021 | -466.00 |
| Mar 31, 2021 | -481.00 |